Obesity Week 2025 Medications Cagrilintide Peptide Cagrilintide Medlabs Peptides Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination ADA2025: Eloralintide vs Cagri in Rats Selective amylin mimetic shows improved tolerability and lean mass preservation Preclinical head to head in lean & DIO rats Eloralintide: Similar weight loss to Anti Obesity Medications in Patients With Heart Failure: Current Evidence and Practical Guidance Circulation: Heart Failure Novel strategies for medical management of obesity: mechanisms, clinical implications, and societal impactsa report from the 25th Annual Harvard Nutrition Obesity Symposium The American Journal of Clinical Nutrition